Screener
MBX Biosciences, Inc. MBX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 9:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210593
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $45,214 | $75,289 |
| Marketable securities | 394,763 | 298,416 |
| Prepaid expenses and other current assets | 8,559 | 7,834 |
| Total current assets | 448,536 | 381,539 |
| Property and equipment, net | 3,133 | 2,735 |
| Right-of-use assets | 453 | 487 |
Item 1. Financial Statements.
FAQ
- What is MBX Biosciences, Inc.'s short-term investments?
- MBX Biosciences, Inc. (MBX) reported short-term investments of $394.76M in Q1 2026.
- How has MBX Biosciences, Inc.'s short-term investments changed year-over-year?
- MBX Biosciences, Inc.'s short-term investments increased by 87.2% year-over-year, from $210.88M to $394.76M.
- What is the long-term trend for MBX Biosciences, Inc.'s short-term investments?
- Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s short-term investments has grown at a 143.9% compound annual growth rate (CAGR), from $50.15M to $298.42M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about MBX Biosciences, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude